| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $50.4M | +33.0% |
| Cost of Revenue | $4.3M | +14.7% |
| Gross Profit | $46.1M | +35.1% |
| R&D Expense | $41.2M | +33.6% |
| SG&A Expense | $16.4M | +22.5% |
| Operating Income | -$28.9M | -32.6% |
| Interest Expense | $89K | -15.2% |
| Pre-tax Income | -$27.8M | -24.4% |
| Income Tax | -$417K |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.4M | -56.4% |
| Short-term Investments | $30.7M | — |
| Accounts Receivable | $7.1M | -48.5% |
| Current Assets | $81.1M | -23.9% |
| Total Assets | $115.5M | -4.1% |
| Current Liabilities | $43.7M | +2.8% |
| Total Liabilities | $78.0M | +15.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.8M | -731.3% |
| Capital Expenditures | $1.1M | +30.1% |
| Investing Cash Flow | -$37.5M | -2658.0% |
| Financing Cash Flow | -$4.2M | -105.4% |
| Free Cash Flow | -$7.8M | -382.0% |
| -140.1% |
| Net Income | -$27.4M | -17.1% |
| EPS (Basic) | -$0.84 | +20.8% |
| EPS (Diluted) | -$0.84 | +20.8% |
| Stockholders' Equity |
| $37.5M |
| -29.1% |